TipRanks

KORY JAMES WENTWORTH Insider Profile

4 Followers
KORY JAMES WENTWORTH, CFO at Entrada Therapeutics Inc, holds 117.28K shares in Entrada Therapeutics Inc (Ticker: TRDA), holds 9.51K shares in Bluebird Bio (Ticker: BLUE).
tipranks
KORY JAMES WENTWORTH

KORY JAMES WENTWORTH
Entrada Therapeutics Inc (TRDA)
CFO

Ranked #15,204 out of 109,193 Corporate Insiders

Profitable Transactions

100%
4 out of 4 Profitable Transactions

Average Return

+36.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$734K
100.00%
A breakdown of KORY JAMES WENTWORTH's holdings

Insider Roles

Entrada Therapeutics Inc
(TRDA)
CFO
Roles that KORY JAMES WENTWORTH holds in companies

Most Profitable Insider Trade

Stock:
Bluebird Bio
(BLUE)
Rating:Informative Sell
Date:Jun 08, 2020 - Jun 08, 2021
Return:+52.50%
The most profitable trade made by KORY JAMES WENTWORTH

KORY JAMES WENTWORTH's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Entrada Therapeutics Inc
Sep 03, 2026
CFO
Uninformative Sell
12.37K
$734.15K
BLUE
Bluebird Bio
Aug 05, 2020
―
Uninformative Sell
5.00K
$47.27K
List of latest transactions for each holding click on a transaction to see KORY JAMES WENTWORTH's performance on stock

KORY JAMES WENTWORTH insider profile FAQ

What is the percentage of profitable transactions made by KORY JAMES WENTWORTH?
The percentage of profitable transactions made by KORY JAMES WENTWORTH is 100%.
    What is the average return per transaction made by KORY JAMES WENTWORTH?
    The average return per transaction made by KORY JAMES WENTWORTH is 36.80%.
      What stocks does KORY JAMES WENTWORTH hold?
      KORY JAMES WENTWORTH holds: TRDA, BLUE stocks.
        What was KORY JAMES WENTWORTH’s latest transaction?
        KORY JAMES WENTWORTH latest transaction was an Uninformative Sell of $12.37K.
          What was KORY JAMES WENTWORTH's most profitable transaction?
          KORY JAMES WENTWORTH’s most profitable transaction was an Informative Sell of BLUE stock on June 8, 2020. The return on the trade was 52.50%.
            What is KORY JAMES WENTWORTH's role in Entrada Therapeutics Inc?
            KORY JAMES WENTWORTH's role in Entrada Therapeutics Inc is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.